Godavari Drugs Limited (BOM:530317)
India
· Delayed Price · Currency is INR 82.89
+2.60 (3.24%)
At close: Mar 10, 2026
Godavari Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 23.73 | 26.23 | 30.85 | 22.76 | 16.38 | Upgrade
|
| Cash & Short-Term Investments | 22.93 | 23.73 | 26.23 | 30.85 | 22.76 | 16.38 | Upgrade
|
| Cash Growth | -23.01% | -9.52% | -14.97% | 35.50% | 38.95% | 14.84% | Upgrade
|
| Accounts Receivable | - | 423.24 | 594.23 | 579.35 | 555.79 | 451.21 | Upgrade
|
| Other Receivables | - | 8.52 | 11.73 | 11.12 | 14.14 | 9.06 | Upgrade
|
| Receivables | - | 441.98 | 614.91 | 599.35 | 576.02 | 465.94 | Upgrade
|
| Inventory | - | 279.41 | 206.51 | 198.56 | 100.34 | 146.5 | Upgrade
|
| Other Current Assets | - | 42.5 | 37.16 | 41.31 | 44.23 | 47.31 | Upgrade
|
| Total Current Assets | - | 787.63 | 884.81 | 870.06 | 743.34 | 676.13 | Upgrade
|
| Property, Plant & Equipment | - | 625.55 | 450.05 | 339.85 | 267.41 | 231.92 | Upgrade
|
| Long-Term Investments | - | 1.13 | 1.13 | 1.02 | 1.02 | 0 | Upgrade
|
| Other Long-Term Assets | - | 16.46 | 11.55 | 3.4 | 2.34 | 3.34 | Upgrade
|
| Total Assets | - | 1,431 | 1,348 | 1,214 | 1,014 | 911.4 | Upgrade
|
| Accounts Payable | - | 287.06 | 316.27 | 246.73 | 433.17 | 295.05 | Upgrade
|
| Accrued Expenses | - | 4.07 | 8.58 | 5.87 | 3.7 | 16.83 | Upgrade
|
| Short-Term Debt | - | 377.33 | 444.58 | 430.25 | 85.61 | 135.89 | Upgrade
|
| Current Portion of Long-Term Debt | - | 27.18 | 21.45 | 23.5 | 27.29 | 23.8 | Upgrade
|
| Current Income Taxes Payable | - | 11.9 | 11.55 | 10.17 | 12.27 | 11.88 | Upgrade
|
| Other Current Liabilities | - | 23.37 | 17.57 | 20.57 | 15.57 | 21.68 | Upgrade
|
| Total Current Liabilities | - | 730.9 | 820 | 737.08 | 577.61 | 505.12 | Upgrade
|
| Long-Term Debt | - | 238.95 | 111.67 | 119.48 | 117.82 | 144.9 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 8.26 | 7.56 | 7.14 | 7.23 | 7.87 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 19.18 | 18.63 | 16.46 | 15.14 | 9.65 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | 0 | - | Upgrade
|
| Total Liabilities | - | 997.3 | 957.86 | 880.16 | 717.8 | 667.54 | Upgrade
|
| Common Stock | - | 75.31 | 75.31 | 75.31 | 75.31 | 75.31 | Upgrade
|
| Additional Paid-In Capital | - | 106.32 | 106.32 | 106.32 | 106.32 | 106.32 | Upgrade
|
| Retained Earnings | - | 246.34 | 202.54 | 147.05 | 109.19 | 56.74 | Upgrade
|
| Comprehensive Income & Other | - | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | Upgrade
|
| Shareholders' Equity | 453.87 | 433.46 | 389.66 | 334.17 | 296.31 | 243.86 | Upgrade
|
| Total Liabilities & Equity | - | 1,431 | 1,348 | 1,214 | 1,014 | 911.4 | Upgrade
|
| Total Debt | 739.28 | 643.46 | 577.7 | 573.22 | 230.73 | 304.58 | Upgrade
|
| Net Cash (Debt) | -716.35 | -619.73 | -551.47 | -542.38 | -207.96 | -288.2 | Upgrade
|
| Net Cash Per Share | -95.27 | -82.35 | -73.25 | -72.06 | -27.63 | -38.26 | Upgrade
|
| Filing Date Shares Outstanding | 7.5 | 7.53 | 7.53 | 7.53 | 7.53 | 7.53 | Upgrade
|
| Total Common Shares Outstanding | 7.5 | 7.53 | 7.53 | 7.53 | 7.53 | 7.53 | Upgrade
|
| Working Capital | - | 56.73 | 64.81 | 132.98 | 165.73 | 171.02 | Upgrade
|
| Book Value Per Share | 60.32 | 57.56 | 51.74 | 44.38 | 39.35 | 32.38 | Upgrade
|
| Tangible Book Value | 453.87 | 433.46 | 389.66 | 334.17 | 296.31 | 243.86 | Upgrade
|
| Tangible Book Value Per Share | 60.32 | 57.56 | 51.74 | 44.38 | 39.35 | 32.38 | Upgrade
|
| Land | - | 22.67 | 0.33 | 0.33 | 0.33 | 0.33 | Upgrade
|
| Buildings | - | 56.5 | 56.5 | 44.59 | 44.59 | 44.03 | Upgrade
|
| Machinery | - | 415.1 | 411.92 | 417.9 | 450.75 | 396.18 | Upgrade
|
| Construction In Progress | - | 299.46 | 183.21 | 90.75 | 4.9 | 7.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.